• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Relationship between CC chemokine expression in the airways of severe asthmatics and steroid resistance

Research Project

Project/Area Number 14570428
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionKEIO UNIVERSITY

Principal Investigator

NAKAMURA Hidetoshi  Keio University, School of Medicine, Assistant, 医学部, 助手 (00217879)

Co-Investigator(Kenkyū-buntansha) NAKAJIMA Takahiro  Keio University, School of Medicine, Assistant, 医学部, 助手 (70306702)
ASANO Koichiro  Keio University, School of Medicine, Assistant Professor, 医学部, 講師 (60192944)
YAMAGUCHI Kazuhiro  Keio University, School of Medicine, Associate Professor, 医学部, 助教授 (30129712)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsasthma / severity / eotaxin / steroid / bradykinin / TGF-β1 / oncostatin-M / TGF-β / CCケモカイン / eotaxin / MCP-4 / IL-5
Research Abstract

Among biomarkers of asthma severity studied, plasma eotaxin level was not significantly affected by corticosteroid treatment, and was associated with the severity of stable asthmatics even in the presence of steroid therapy. There was a significant correlation between the pretreatment levels of plasma eotaxin and the extent of functional improvement after steroid treatment in unstable asthmatics. These results suggest that plasma eotaxin level is a marker of disease activity and/or treatment response to steroids in unstable asthma.
Bradykinin concentrations in exhaled breath condensate in asthmatics were detectable but were not different from those in normal subjects. Eotaxin production in human fetal fibroblast (HFL-1) was slightly increased by Bradykinin. TNF-α strongly induced eotaxin production in this cell line which was moderately inhibited by the addition of oncostatin-M or TGF-β1. The inhibitory effects of steroid on eotaxin production were further enhanced by coincubation with TGF-β1.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report

Research Products

(10 results)

All Other

All Publications (10 results)

  • [Publications] Tateno H, Nakamura H, et al.: "Plasma eotaxin level and severity of asthma treated with corticosteroid."Respir.Med.. (in press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 仲村秀俊, 石坂彰敏: "肺線維化におけるケモカインとケモカインレセプターの関与"分子呼吸器病. 6(4). 290-295 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Asano K, Shiomi T, et al.: "Leukotriene C_4 synthase gene A(-444)C polymorphism and clinical response to a cys-LT_1 antagonist, pranlukast, in Japanese patients with moderate asthma."Pharmacogenetics. 12. 565-570 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Minematsu N, Nakamura H, et al.: "Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema."Thorax. 58. 623-628 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tateno H, Nakamura H, Minematsu N, Nakajima T, Takahashi S, Nakamura M, Fukunaga K, Asano K, Lilly CM, Yamaguchi K.: "Plasma eotaxin level and severity of asthma treated with corticosteroid."Respir Med. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakamura H, Ishizaka A.: "Roles of chemokines and their receptors in the development of pulmonary fibrosis."Bunshi-Kokyukibyo (Respiratory Molecular Medicine). 6(4). 290-295 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Asano K, Shiomi T, Hasegawa N, Nakamura H, Kudo H, Matsuzaki T, Hakuno H, Fukunaga K, Shiomi T, Suzuki Y, Kanazawa M, Yamaguchi: "Leukotriene C_4 synthase gene A(-444)C polymorphism and clinical response to a cys-LT_1 antagonist, Pranlukast, in Japanese patients with moderate asthma."Pharmacogenetics. 12. 565-570 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Minematsu N, Nakamura H, Iwata M, Tateno H, Nakajima T, Takahashi S, Fujishima S, Yamaguchi K.: "Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema."Thorax. 58. 623-628 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tateno H, Nakamura H, et al.: "Plasma eotaxin level and severity of asthma treated with corticosteroid"Respiratory Medicine. (in press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] 仲村 秀俊, 石坂 彰敏: "肺線維化におけるケモカインとケモカインレセプターの関与"分子呼吸器病. 6・4. 290-295 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi